Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI)

Table 1

Characteristics of the studied population.

Breast Density	Histological type	Molecular type	NAC Regimen	CEM Response	FFDM Response	MRI Response	Histopathological response
ACR c	IDC	Luminal B	TAC	PR	PR	PR	pPR
ACR d	IDC	Luminal B	AC-T	CR	PR	PR	pCR
ACR d	IDC	Luminal B	AC-T	CR	CR	CR	pPR
ACR c	Mixed	Luminal B	FAC	PR	PR	PR	pPR
ACR d	IDC	Luminal A	AC-T	SD	SD	SD	pSD
ACR b	IDC	Her2+	TCH	PR	SD	PR	pPR
ACR d	IDC	Luminal B	TAC	CR	PR	PR	pPR
ACR d	IDC	Luminal A	AC	PD	CR	PD	pPD
ACR a	IDC	Luminal B	AC-T	PR	PR	PR	pPR
ACR b	IDC	Triple-negative	AC-T	PR	CR	PR	pCR
ACR d	IDC	Triple-negative	AC	SD	CR	SD	pSD
ACR d	IDC	Triple-negative	AC	PR	PR	SD	pPR
ACR c	IDC	Triple-negative	AC-T	CR	CR	CR	pCR
ACR b	Mixed	Luminal B	AC-T	PR	PR	PR	pPR
ACR b	IDC	Triple-negative	AC-T	PR	PR	PR	pPR
ACR c	IDC	Luminal B	AC-T	CR	PR	PR	pPR
ACR b	IDC	Luminal B	AC-TH	CR	PR	CR	pCR
ACR b	IDC	Luminal B	FAC-T	PR	PR	PR	pPR
ACR b	IDC	Triple-negative	AC-T	CR	CR	CR	pCR
ACR d	ILC	Luminal A	AC-T	SD	SD	SD	pSD
ACR c	IDC	Luminal B	AC-T	PR	PR	PR	pPR
ACR b	IDC	Luminal A	AC-T	CR	CR	PR	pPR
ACR c	IDC	Triple-negative	AC-T	CR	CR	CR	pPR
ACR c	IDC	Luminal B	TAC	CR	CR	CR	pCR
ACR a	IDC	Triple-negative	AC-T	SD	SD	SD	pSD
ACR c	IDC	Luminal A	AC-T	PR	CR	PR	pPR
ACR c	IDC	Luminal B	AC-T	CR	PR	CR	pCR
ACR d	IDC	Luminal B	AC-T	PD	PD	PD	pPD
ACR c	IDC	Luminal B	AC-T	CR	CR	CR	pCR
ACR c	Mixed	Luminal B	AC-T	CR	PR	PR	pPR
ACR b	IDC	Triple-negative	AC-T	PR	PR	PR	pPR
ACR d	IDC	Luminal A	FAC-T	PR	PR	PR	pPR
ACR c	IDC	Triple-negative	FAC-T	PR	PR	PR	pPR

NAC: neoadjuvant chemotherapy; FFDM: full-field digital mammography; CEM: contrast-enhanced mammography; MRI: magnetic resonance imaging; CR: complete response; PR: partial response; SD: stable disease; PD progressive disease.